10.1002/anie.202104252
Angewandte Chemie International Edition
COMMUNICATION
[4] a) S. E. Denmark, T. Wynn, G. L. Beutner, J. Am. Chem. Soc. 2002, 124,
13405; b) S. Denmark, G. L. Beutner, T. Wynn, M. D. Eastgate, J. Am. Chem.
Soc. 2005, 127, 3774; c) G. E. Keck, D. Krishnamurthy, J. Am. Chem.
Soc.1995, 117, 2363; d) I. Shiina, Chem. Rec. 2014, 14, 144.
[5] A. Bhowmik, S. V. Mulay, R. A. Fernandes, Asian J. Org. Chem. 2019, 8,
1534.
[6] a) L. F. Tietze, J. Zinngrebe, D. A. Spiegl, F. Stecker, Heterocycles 2007, 74,
473; b) L. F. Tietze, D. A. Spiegl, F. Stecker, J. Major, C. Raith, C. Große,
Chem. Eur. J. 2008, 14, 8956; c) L. F. Tietze, S. Jackenkroll, J. Hierold, L.
Ma, B. Waldecker, Chem. Eur. J. 2014, 20, 8628.
[7] a) G. Yin, X. Mu, G. Liu, Acc. Chem. Res. 2016, 49, 2413; b) C. Chen, Y.
Luo, L. Fu, P. Chen, Y. Lan, G. Liu, J. Am. Chem. Soc. 2018, 140, 1207; c)
X. Li, P. Chen, G. Liu, Angew. Chem. Int. Ed. 2018, 57, 15871; Angew. Chem.
2018, 130, 16097.
[8] M. Li, F. Yu, X. Qi, P. Chen, G. Liu, Angew. Chem. Int. Ed. 2016, 55, 13843;
Angew. Chem. 2016, 128, 14047.
synthesis of natural product (+)-dihydrokavain (64) which possesses
sedative, anti-convulsive, anesthetic, and antifungal properties.[16] Chiral
protected amino alcohol 66 and β-hydroxy alkylcarboxylic acid 67 could
be obtained by Curtius rearrangement and deprotection, respectively.
With this strategy, the readily available alkene 69 derived from
commercially available benzyl bromide 68 could be converted to
biologically active natural product (−)-erythrococcamide B[17] (70) in
four steps via a sequential oxycarbonylation, amidation, deprotection,
and cyclization (Scheme 3e). It was noteworthy that only one column
purification was needed using this route, providing 70 in a total yield of
44% with 90% ee
In summary, we have developed the first intermolecular Pd(II)-
catalyzed asymmetric oxycarbonylation of terminal alkenes. This
method has properties of wide substrate scope, excellent regio- and
enantioselectivity control, mild conditions, and operationally simple
processes which offers an efficient and easy access to β-hydroxy
alkylcarboxylic acids. The strategy by introducing sterically moderate
groups into C-6 position of Pyox ligand palys an important role in the
asymmetric intermolecular oxypalladation process.
[9] a) X. Qi, C. Chen, C. Hou, L. Fu, P. Chen, G. Liu, J. Am. Chem. Soc. 2018,
140, 7415; b) C. Chen, P. M. Pflüger, P. Chen, G. Liu, Angew. Chem. Int. Ed.
2019, 58, 2392; Angew. Chem. 2019, 131, 2414; c) C. Hou, P. Chen, G. Liu,
Angew. Chem. Int. Ed. 2020, 59, 2735; Angew. Chem. 2020, 132, 2757; d) X.
Li, X. Qi, C. Hou, P. Chen, G. Liu, Angew. Chem. Int. Ed. 2020, 59, 17239;
Angew. Chem. 2020, 132, 17392.
[10] B. Tian, P. Chen, X. Leng, G. Liu, Nat. Catal. 2021, 4, 172.
[11] With regard to the convenient detection of ee value, the crude product acid
was treated with MeOH followed by TMSCHN2 to give the corresponding
methyl ester. For details, see SI.
[12] N. J. Race, C. S. Schwalm, T. Nakamuro, M. S. Sigman, J. Am. Chem. Soc.
2016, 138, 15881.
[13] C. Buonocore, P. Tedesco, G. A. Vitale, F. Palma Esposito, R. Giugliano, M.
C. Monti, M. V. D’Auria, D. de Pascale, Mar. Drugs 2020, 18, 269.
[14] M. Igarashi, Y. Takahashi, T. Shitara, H. Nakamura, H. Naganawa, T.
Miyake, Y. Akamatsu, J. Antibiot. 2005, 58, 327.
[15] Deposition Number 2053659 (for 62) contains the supplementary
crystallographic data for this paper. These data are provided free of charge
by the joint Cambridge Crystallographic Data Centre and
Acknowledgements
We are grateful for financial support from the National Natural Science
Foundation of China (Nos. 21532009, 21971255, 21821002, 21790330
and 21761142010), the Science and Technology Commission of
Shanghai Municipality (Nos. 19590750400 and 17JC1401200), the
Strategic Priority Research Program (No. XDB20000000) and the Key
Research Program of Frontier Science (QYZDJSSW-SLH055) of the
Chinese Academy of Sciences. P.C. also thanks the Youth Innovation
Promotion Association CAS (No.2018292).
Fachinformationszentrum
Karlsruhe
Access
Structures
service
Conflict of interest
[16] A. Kamal, T. Krishnaji, G. B. R. Khanna, Tetrahedron Lett. 2006, 47, 8657.
[17] Z. Latif, T. G. Hartley, M. J. Rice, R. D. Waigh, P. G. Waterman, J. Nat.
Prod. 1998, 61, 614.
The authors declare no competing financial interest.
Keywords: enantioselective oxycarbonylation • palladium-catalyzed •
terminal alkenes • β-hydroxy alkylcarboxylic acids
[1] a) E. S. Istvan, J. Deisenhofer, Science 2001, 292, 1160; b) J. A. Tobert, Nat.
Rev. Drug Discovery 2003, 2, 517; c) R. Uchida, A. Kondo, A. Yagi, K.
Nonaka, R. Masuma, K. Kobayashi, H. Tomoda, J. Antibiot. 2019, 72, 134;
d) J. Quirk, M. Thornton, P. Kirkpatrick, Nat. Rev. Drug. Discovery 2003, 2,
769; e) M. Davidson, P. Ma, E. A. Stein, A. M. Gotto, A. Raza, R. Chitra, H.
Hutchinson, J. Cardiol. 2002, 89, 268; f) H. Lessmann, J. Krupa, H. Lackner,
K. Schmidt-Bꢀse, G. M. Sheldrick, Z. Naturforsch. 1993, 48, 672; g) A. Endo,
M. Kuroda, Y. Tsujita, J. Antibiot. 1976, 29, 1346.
[2] N. Andrushko, V. Andrushko, Asymmetric Hydrogenation of C=O and C=N
Bonds in Stereoselective Synthesis, Wiley, Hoboken, 2013.
[3] For reviews on the ruthenium-catalyzed asymmetric hydrogenation, see: a)
R. Noyori, Asymmetric Catalysis in Organic Synthesis, Wiley-Interscience,
New York, 1994; b) T. Ohkuma, R. Noyori, Enantioselective Ketone and β-
Keto Ester Hydrogenations (Including Mechanisms), Wiley-VCH,
Weinheim, 2007; c) R. Noyori, Angew. Chem. Int. Ed. 2002, 41, 2008; Angew.
Chem. 2002, 114, 2108; d) W. Tang, X. Zhang, Chem. Rev. 2003, 103, 3029;
For some selective examples, see: e) J.-H. Xie, X.-Y. Liu, X.-H. Yang, J.-B.
Xie, L.-X. Wang, Q.-L. Zhou, Angew. Chem. Int. Ed. 2012, 51, 201; Angew.
Chem. 2012, 124, 205; f) D.-H. Bao, H.-L. Wu, C.-L. Liu, J.-H. Xie, Q.-L.
Zhou, Angew. Chem. Int. Ed. 2015, 54, 8791; Angew. Chem. 2015, 127, 8915;
g) W. Jiang, Q. Zhao, W. Tang, Chin. J. Chem. 2018, 36, 153; h) Y. Li, S.
Yu, X. Wu, J. Xiao, W. Shen, Z. Dong, J. Gao, J. Am. Chem. Soc. 2014, 136,
4031; i) S. Jeulin, S. Duprat de Paule, V. Ratovelomanana-Vidal, J.-P. Genêt,
N. Champion, P. Dellis, Angew. Chem. Int. Ed. 2004, 43, 320; Angew. Chem.
2004, 116, 324.
This article is protected by copyright. All rights reserved.